home *** CD-ROM | disk | FTP | other *** search
- BUSINESS, Page 45Business NotesANTITRUSTFormula for Controversy
-
-
-
- When most people gaze at a newborn child, they see a bundle
- of joy. The makers of infant formula see something else: a
- bundle of loot. That's the argument of industry critics who
- claim that the leaders of the $1.5 billion formula business
- have unfairly boosted their prices 150% during the 1980s. Last
- week the state of Florida filed a lawsuit in federal court
- against the top U.S. formula makers: Abbott Laboratories (maker
- of Similac), American Home Products (Nursoy) and Bristol-Myers
- Squibb (Enfamil). The civil suit accuses the companies of
- fixing and inflating formula prices.
-
- Antitrust accusations have dogged the firms for months. In
- a congressional hearing last May, Senator Howard Metzenbaum of
- Ohio denounced the price increases and their "devastating"
- impact on government programs that buy infant formula for
- low-income families. Metzenbaum's hearing spurred a still
- active investigation by the Federal Trade Commission. The
- companies deny that any conspiracy took place.
-
-
-
-
-
-
-
-
-